Why Cue Health Blasted Higher Today
Monday was a very good day for stocks in general, but it was a standout day for healthcare diagnostics specialist Cue Health (NASDAQ: HLTH). On its website, Cue Health isn't shy to point out that it's the maker of the first molecular diagnostic test for COVID-19 approved by the U.S. Food and Drug Administration (FDA). Cue Health's COVID diagnostic test is also a product that can be administered at home with no training.